Cancer Test Startup’s IPO Buzz: What’s Up?

Caris Life Sciences, a company that uses AI to personalize cancer treatment, just upped its IPO price range—meaning investors are lining up for a piece of the action. Why should you care? More IPOs like this signal Wall Street is warming up again, which could mean more innovation (and maybe even better tech for your next doctor visit). Plus, if you’re into investing, it’s a sign to keep an eye on the health tech space! #IPO #HealthTech #InvestingTips #Business #EntrepreneurshipStartup